Foreign medical device innovators accessing the Chinese market remain at a disadvantage to local companies, even after the recent regulatory pathway revision.
The latest revision to China's Regulation for Supervision and Administration of Medical Devices (RSAMD) – State Council Order No 739 – does not do enough to help foreign medtech innovators gain access to the Chinese market.
That is the contention of law firm Ropes & Gray, in a whitepaper compiled after the “2021 Medtech Regulatory Affairs...
Fallouh Healthcare has received £305,050 in grant funding from Innovate UK as part of the European Union’s Eureka Eurostars program. The company aims to detect cardiac tamponade, a condition that affects patients after heart surgery. Currently, there is no way to accurately diagnose the condition.
Healthcare product industries await publication of the NHS 10-Year Plan, due out the coming days, which will focus on health generally not just the NHS, UK health secretary Wes Streeting said during a final prelaunch event on 24 June.
From June 30, new European Commission rules will attempt to redress an imbalance in medtech trade between the EU and the People’s Republic of China.
